COVID-19 vaccine post-marketing surveillance: Cardiovascular doctors have a role to play!

Fournier, Dorine; Bouchet, Amandine; Lebrun-Vignes, Bénédicte

Fournier, Dorine; Bouchet, Amandine; Lebrun-Vignes, Bénédicte.

Fournier D; Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, Centre Régional de Pharmacovigilance, Hôpital Universitaire Saint-Antoine, 75012 Paris, France. Electronic address: dorine.fournier@aphp.fr.
Bouchet A; Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, Centre Régional de Pharmacovigilance, Hôpital Universitaire Pitié-Salpêtrière, 75013 Paris, France.
Lebrun-Vignes B; Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, Centre Régional de Pharmacovigilance, Hôpital Universitaire Saint-Antoine, 75012 Paris, France; Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, Centre Régional de Pharmacovigilance, Hôpital Universitaire Pitié-Salpêtrière, 75013 Paris, France.

Arch Cardiovasc Dis ; 114(8-9): 521-523, 2021.

Article in English | MEDLINE | ID: covidwho-1491565

Subject(s)

COVID-19 Vaccines; COVID-19; Adverse Drug Reaction Reporting Systems; Humans; Pharmacovigilance; SARS-CoV-2

Keywords

COVID-19 vaccine; Cardiovascular effects; Effets cardiovasculaires; Pharmacovigilance post-commercialisation; Post-marketing pharmacovigilance; Post-marketing surveillance; Surveillance post-commercialisation; Vaccin COVID-19

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Arch Cardiovasc Dis Journal subject: Vascular Diseases / Cardiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google